InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the complete record of transactions filed by Pankovcin Corinne, 首席财务官. Director active across 2 companies, notably Aditx Therapeutics, Inc.. Aggregated, 3 reports have been recorded. Breakdown: 1 buy · 1 sell. Total volume traded: €3. History available since 4 June 2021. The latest transaction was disclosed on 25 November 2025 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条
Corinne Pankovcin is the Chief Financial Officer at Aditx Therapeutics, Inc. In this role, she oversees the company's financial operations, including budgeting and risk management. Her expertise is crucial for ensuring the company's financial health.